跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 825 条关于
“Amylin”
全部
825
临床试验
568
药物
69
机构
33
资讯
155
去年
Amylin Analogs Emerge as Key Players in Next-Generation Obesity Treatments
去年
University of Oklahoma Researchers Unlock Amylin Receptor Mechanisms for Next-Generation Obesity Drugs
去年
Structure Therapeutics Advances Oral Amylin Agonist ACCG-2671 for Obesity Treatment
去年
AbbVie Enters Obesity Market with $350M Gubra Deal for Novel Amylin Analog
去年
Metsera's Monthly Amylin Injection Achieves 8.4% Weight Loss in Phase I Trial
2年前
Novo Nordisk's Amycretin Pill Shows Promising 13% Weight Loss in Early Trial
5个月前
Amylin Drug Development Surges with $19 Billion Investment as Nearly 40 Programs Target Obesity Treatment
去年
Verdiva Bio Advances Once-Weekly Oral GLP-1 and Amylin Therapies for Obesity Treatment
12个月前
Zealand Pharma Explores Direct-to-Consumer Sales for Novel Amylin-Based Obesity Drug Petrelintide
去年
Metsera's MET-233i Achieves 8.4% Weight Loss in Phase 1 Trial, Enabling First Monthly Amylin-GLP-1 Combination
第 1 页,共 16 页
上一页
下一页